Rectal Cancer Consortium
NCT01835925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2014-05-01
Summary
The purpose of this study is to study which genes are abnormal in rectal cancer and see if this predicts how well chemotherapy and radiation will reduce the size of cancer and whether cancer recurs after surgery.
Conditions
Interventions
- GENETIC
-
Tissue specimen
Sponsors & Collaborators
-
Brown University
lead OTHER
Principal Investigators
-
Howard Safran, MD · Brown University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Identification of New Colorectal Cancer Genes
NCT00582335 ·Status: COMPLETED
-
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
NCT06565052 ·Status: RECRUITING ·Phase: NA
-
Genetic Study of Young Patients With Colorectal Cancer
NCT00044967 ·Status: COMPLETED
-
Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer
NCT06534242 ·Status: COMPLETED
-
IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer
NCT03637686 ·Status: ACTIVE_NOT_RECRUITING
-
Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials
NCT05910099 ·Status: NOT_YET_RECRUITING
-
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
NCT06568679 ·Status: RECRUITING
-
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
NCT05102110 ·Status: RECRUITING
-
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360 ·Status: UNKNOWN
-
Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool
NCT01803009 ·Status: COMPLETED ·Phase: NA
-
Molecular Markers of Prognosis in Colorectal Cancer Patients
NCT00220142 ·Status: COMPLETED
-
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT00582829 ·Status: COMPLETED
-
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
NCT00625625 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Detection and Risk Stratification of Colorectal Cancer Based on miRNA Platform
NCT06351384 ·Status: NOT_YET_RECRUITING
-
Gene Testing in Patients With Colon Cancer
NCT00003571 ·Status: COMPLETED
-
Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps
NCT04160832 ·Status: COMPLETED
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Relapse Markers for Colorectal Cancer
NCT04920955 ·Status: COMPLETED
-
Facilitating Risk-Appropriate Colorectal Cancer Testing - Testing the Cancer Risk Intake System (CRIS)
NCT02368236 ·Status: COMPLETED ·Phase: NA
-
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
NCT02198092 ·Status: COMPLETED
-
Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy
NCT01934179 ·Status: TERMINATED
-
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT04624555 ·Status: RECRUITING
-
Genetic Study of Patients and Families With a History of Colorectal Cancer
NCT00003648 ·Status: COMPLETED
-
Young-Onset Colorectal Cancer
NCT02863107 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment
NCT02813928 ·Status: COMPLETED ·Phase: NA